MAYO CLINIC PLATFORM_ACCELERATE
Meet the October 2025 cohort of innovative health tech startups
Mayo Clinic Platform_Accelerate is a 30-week accelerator designed to fast-track early-stage health-tech AI startups toward clinical deployment by providing access to de-identified Mayo Clinic data sets, tailored mentorship from a Mayo Clinic expert, and education in relevant topics such as regulatory approval, clinical workflow integration, technology management, and the health technology ecosystem.
Meet the newest cohort:
Bowhead Health is developing a radiogenomics platform that uses imaging to predict genomic mutations and generate probability scores. These scores support treatment guideline checks and clinical trial matching, helping clinicians make more informed decisions.
Cleancard is a YC-backed and VC funded startup innovating at the intersection of synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test. Cleancard is bringing lab-grade diagnostics and biomarker tracking into every patient’s home with a 30-minute non-invasive test that turns patients’ homes into distributed healthcare hubs and enables them to monitor their health on demand.
Dart Health is the fastest way to deploy AI across any hospital. Its engineering team works on-site to solve operational and clinical problems - side by side with staff. Using Dart Health’s AI clinical-reasoning platform, the company deploys, fine-tunes, and builds end-to-end AI applications rapidly from AI oncology dosing assistants with access to modern research to earlier identification of malnutrition.
Kanjo Health is transforming paediatric neurodevelopmental care with a unique, evidence-based digital platform for ADHD and autism. We bring together cutting-edge AI, clinician expertise, and lived-experience insights to provide earlier, more accurate identification and personalised care pathways. From pre-diagnostic risk analytics to interdisciplinary care delivery and parent support, Kanjo equips families, clinicians, and health systems with the tools to act sooner and more effectively. Trusted by global partners across the NHS, Middle East, and US, Kanjo is setting a new standard in accessible, scalable, and compassionate care because every child deserves support as unique as they are.
Koroid is an intelligent platform that transforms how health systems turn clinical and operational signals into action. Its software and automated pipelines forecast demand, orchestrate logistics, and deploy workforce and core resources at the right time and place - reducing burnout, lowering costs, and improving outcomes. Founded by a physician and powered by a world-class technical team, Koroid partners with leading institutions as a long-term ally in transforming care delivery at scale.
MedLink Global is pioneering AI-powered solutions to transform psychiatric care. Building on its validated psychopathology assessment platform, MaiNDS, MedLink is advancing toward treatment guidance that incorporates both psychiatric and physical health comorbidities. This next-generation solution is designed to shorten trial-and-error care by delivering more accurate diagnoses, personalized treatment recommendations, and longitudinal patient insights. The treatment co-pilot model leverages multi-dimensional clinical data to ensure robust, real-world applicability—bringing precision psychiatry into everyday practice, supporting clinicians with actionable treatment suggestions and improving outcomes for patients.
MyAtlas Health is an AI-powered mental wellness platform transforming how we predict and prevent mental health crises. Its patent-pending technology analyzes everyday signals from phones and wearables to detect early signs of decline with up to 90% accuracy—well before symptoms escalate. For individuals, MyAtlas provides personalized recommendations, guided programs, and real-time support to build resilience and improve wellbeing. For providers, it unlocks new revenue streams with automated risk tracking, engagement insights, and billing support. By making prevention measurable, accessible, and culturally relevant, MyAtlas bridges the gap between wellness and clinical care, helping reduce the $280B annual cost of untreated mental health.
Ordinatrum Health is transforming critical care with FDA-cleared solutions, including the Virtual ICU and MDI (Medical Device Integration) platform. By unifying patient data and delivering AI-driven, near real-time insights, Ordinatrum empowers healthcare providers to detect risks earlier, streamline workflows, and reduce information overload. Its scalable, interoperable platform enhances collaboration across care teams, enabling more coordinated and effective decision-making. Designed for the evolving demands of intensive and acute care, Ordinatrum supports next-generation connected and virtual care models, helping providers deliver safer, smarter, and more efficient treatment while improving patient outcomes and elevating the overall standard of critical care delivery.
ProMed is putting a full health team in your pocket - helping people live healthier for longer. By combining blood and DNA testing with wearable data, its multimodal AI uncovers hidden health risks early and creates personalized action plans, all reviewed by human physicians. Promed delivers proactive care at a fraction of the cost of traditional executive health programs.
RTHM provides technology-enabled care for complex and underserved chronic conditions, including Long COVID and ME/CFS. The mission is to make healing possible for people with complex or unexplained illness by delivering faster, better paths to diagnosis and treatment—built with data, understanding, and expertise the traditional system can't offer. RTHM imagines a world where every person, every symptom, every treatment experience, every datapoint fuels a smarter system so we're always getting the best possible care.
Radical is enabling every patient to access the number one doctor in the world by training AI models on leading academic centers and scaling that knowledge to every patient. Initially focused on cancer care, Radical offers a patient-facing second opinion service that allows anyone, anywhere, to receive personalized treatment recommendations. The company partners with leading cancer centers like UCSF, where they've trained AI models on a dataset of over 6 million multimodal patient records.
Interested in learning more?
Explore details about the program, hear from previous graduates, and learn more about how to apply at the Accelerate website.
